Published in Am J Clin Pathol on July 01, 1992
Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02
Serological evidence of past hepatitis B infection in liver donor and hepatitis B infection in liver allograft. Lancet (1995) 1.68
In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Cell Sci (1995) 1.55
Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol (1993) 1.25
Disruption of the RAD52 gene alters the spectrum of spontaneous SUP4-o mutations in Saccharomyces cerevisiae. Genetics (1989) 1.23
Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. Ann Intern Med (1988) 1.11
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat (2011) 1.04
Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology (1995) 0.99
Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine (2011) 0.94
Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation. Oncogene (2006) 0.92
Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology (1991) 0.92
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (1999) 0.91
Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis. Hepatology (1986) 0.89
Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology (1990) 0.88
Altered enteroendocrine cell expression in T cell receptor alpha chain knock-out mice. Microsc Res Tech (2000) 0.87
Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. Vaccine (2010) 0.87
The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. J Immunol (1990) 0.83
Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat (2009) 0.82
Tissue-specific regulation of IL-4 mRNA expression in human tonsil. J Immunol (1994) 0.81
Women experience higher rates of adverse events during hepatitis C virus therapy in HIV infection: a meta-analysis. J Acquir Immune Defic Syndr (2010) 0.78
Treatment of chronic type B hepatitis with multiple ten-day courses of adenine arabinoside monophosphate. J Med Virol (1985) 0.78
Abnormal response to a human B cell growth factor in patients with common variable immunodeficiency (CVI). J Allergy Clin Immunol (1991) 0.78
FK 506: reversal of humorally mediated rejection following ABO-incompatible liver transplantation. Transplant Proc (1991) 0.77
Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis. J Interferon Res (1986) 0.77
Metastasis suppressors: basic and translational advances. Curr Pharm Biotechnol (2011) 0.77
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology (1999) 0.75
Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HIV infection and primary myelodysplasia. Br J Haematol (1994) 0.75
Regional expression of murine intestinal immune cells in normal and isografted intestine. Cell Immunol (1995) 0.75
FK506: inhibition of humoral mechanisms of hepatic allograft rejection. Transplantation (1992) 0.75
Day-5 protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery (1992) 0.75
Base-pair substitutions alter the site-specific mutagenicity of UV and MNNG in the SUP4-o gene of yeast. Mutat Res (1989) 0.75
Doppler sonographic evaluation of the portal vein: effects of intravenous dodecafluoropentane. J Ultrasound Med (1997) 0.75